Dr. Reddy’s Laboratories enters hospital nutrition segment with Celevida Maxx in India
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY), today announced the entry…
Branded Markets (India and Emerging Markets)
Dr. Reddy’s Laboratories announces the launch of AVIGAN(R) (Favipiravir) in India
Hyderabad, India, August 19, 2020 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY,…